Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasms

被引：6

作者：

Elena, Chiara ^{[1
]}

Rumi, Elisa ^{[1
]}

Portolan, Monica ^{[1
]}

Della Porta, Matteo G. ^{[1
]}

Pascutto, Cristiana ^{[1
]}

Passamonti, Francesco ^{[2
,3
]}

机构：

[1] Univ Pavia, Fdn IRCCS Policlin San Matteo, Dept Hematol Oncol, I-27100 Pavia, Italy

[2] Osped Circolo Varese, Dept Internal Med, Div Hematol, Varese, Italy

[3] Fdn Macchi, Varese, Italy

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2011年 / 96卷 / 08期

关键词：

myeloproliferative neoplasm; JAK2; telomere; POLYCYTHEMIA-VERA; GRANULOCYTES; DISEASES; CELLS;

D O I：

10.3324/haematol.2011.047803

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1236 / 1238

页数：3

共 12 条

[1] Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms [J].

Bernard, L. ;

Belisle, C. ;

Mollica, L. ;

Provost, S. ;

Roy, D-C ;

Gilliland, D. G. ;

Levine, R. L. ;

Busque, L. .

LEUKEMIA, 2009, 23 (02) :287-291

[2] Mechanisms of Disease: Telomere Diseases. [J].

Calado, Rodrigo T. ;

Young, Neal S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (24) :2353-2365

[3] Clonal granulocytes in polycythaemia vera and essential thrombocythaemia have shortened telomeres [J].

Ferraris, AM ;

Pujic, N ;

Mangerini, R ;

Rapezzi, D ;

Gallamini, A ;

Racchi, O ;

Casciaro, S ;

Gaetani, GF .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (03) :391-393

[4] High molecular response rate of polycythemia vera patients treated with pegylated interferon α-2a [J].

Kiladjian, Jean-Jacques ;

Cassinat, Bruno ;

Turlure, Pascal ;

Cambier, Nathalie ;

Roussel, Murielle ;

Bellucci, Sylvia ;

Menot, Marie-Laurence ;

Massonnet, Gerald ;

Dutel, Jean-Luc ;

Ghomari, Kamel ;

Rousselot, Philippe ;

Grange, Marie-Jose ;

Chait, Yasmina ;

Vainchenker, William ;

Parquet, Nathalie ;

Abdelkader-Aljassem, Lina ;

Bernard, Jean-Francois ;

Rain, Jean-Didier ;

Chevret, Sylvie ;

Chomienne, Christine ;

Fenaux, Pierre .

BLOOD, 2006, 108 (06) :2037-2040

[5] JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations [J].

Pardanani, A. ;

Vannucchi, A. M. ;

Passamonti, F. ;

Cervantes, F. ;

Barbui, T. ;

Tefferi, A. .

LEUKEMIA, 2011, 25 (02) :218-225

[6] Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders [J].

Passamonti, F ;

Rumi, E ;

Pietra, D ;

Della Porta, MG ;

Boveri, E ;

Pascutto, C ;

Vanelli, L ;

Arcaini, L ;

Burcheri, S ;

Malcovati, L ;

Lazzarino, M ;

Cazzola, M .

BLOOD, 2006, 107 (09) :3676-3682

[7] A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications [J].

Passamonti, F. ;

Rumi, E. ;

Pietra, D. ;

Elena, C. ;

Boveri, E. ;

Arcaini, L. ;

Roncoroni, E. ;

Astori, C. ;

Merli, M. ;

Boggi, S. ;

Pascutto, C. ;

Lazzarino, M. ;

Cazzola, M. .

LEUKEMIA, 2010, 24 (09) :1574-1579

[8] Deep sequencing reveals double mutations in cis of MPL exon 10 in myelloproliferative neoplasm's [J].

Pietra, Daniela ;

Brisci, Angela ;

Rumi, Elisa ;

Boggi, Sabrina ;

Elena, Chiara ;

Pietrelli, Alessandro ;

Bordoni, Roberta ;

Ferrari, Maurizio ;

Passamonti, Francesco ;

De Bellis, Gianluca ;

Cremonesi, Laura ;

Cazzola, Mario .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (04) :607-611

[9]

RUELLA M, 2010, ASH ANN M, V116, P1975

[10] Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood [J].

Rufer, N ;

Brümmendorf, TH ;

Kolvraa, S ;

Bischoff, C ;

Christensen, K ;

Wadsworth, L ;

Schulzer, M ;

Lansdorp, PM .

JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (02) :157-167

← 1 2 →